Approval · Notice of Compliance 12221 · 2011
PUREGON: Notice of Compliance 12221
Issued March 25, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12221
- Date
- March 25, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Human gonadotropin
Products in this notice
Medicinal ingredients
- FOLLITROPIN BETA 50 UNIT per 0.5ML
- FOLLITROPIN BETA 100 UNIT per 0.5ML
- FOLLITROPIN BETA 833 UNIT per ML
- FOLLITROPIN BETA 75 UNIT per 0.5ML
- FOLLITROPIN BETA 150 UNIT per 0.5ML